Century Therapeutics, Inc. — Director's Dealing 2024

Mar 12, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Century Therapeutics, Inc. (IPSC)
CIK: 0001850119
Period of Report: 2024-03-07

Reporting Person: Levitsky Hyam (President of R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-07	Common Stock	A	24000	—	Acquired	24000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-07	Stock Option (right to buy)	$5.32	A	146000	Acquired	2034-03-07	Common Stock (146000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	536544	Indirect

Footnotes

F1: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs vest 25% on March 7, 2025, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock.

F2: The option vests 25% on March 7, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.